Consolidated statement of comprehensive income

Revenue

8.4

14.1

25.2

31.2

40.1

% gross profit to sales

77%

77%

83%

88%

91%

Research and development expenses

(12.4)

(17.0)

(29.7)

(32.3)

(36.4)

Other administrative expenses

(1.8)

(2.6)

(3.0)

(3.2)

(3.4)

Amortisation

–

(2.0)

(10.2)

(10.2)

(10.6)

Share-based compensation

(0.7)

(1.6)

(2.7)

(1.9)

(1.5)

Share of loss of associate

–

(0.2)

(0.3)

(0.6)

–

Operating loss

(8.5)

(11.2)

(25.1)

(20.9)

(15.3)

Investment income

1.0

2.8

4.5

3.6

0.6

Finance gains/(costs)

–

(0.1)

(0.8)

(2.3)

0.9

Loss after taxation

(6.5)

(7.1)

(19.2)

(16.7)

(10.2)

Consolidated cash flow statement

Net cash outflow from operations

(2.5)

(7.9)

(3.7)

(3.6)

(4.3)

Net taxes received

1.0

1.4

2.2

2.9

0.5

Interest received

1.0

2.8

4.5

3.6

0.6

Net capital expenditure

(1.3)

(2.4)

0.6

(1.6)

(1.0)

Net cash acquired with Innovata acquisition

–

17.1

–

–

–

Investment associates in a

–

(0.2)

–

–

–

Consolidated balance sheet

Cash and cash equivalents

16.8

77.0

78.8

74.0

64.1

Shareholders' equity

16.6

182.0

169.5

154.9

147.1